UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026829
Receipt number R000030797
Scientific Title Comparative study between effects of insulin degludec and glargine U300 on nighttime blood glucose fluctuation -Investigasion using flash glucose monitoring system-
Date of disclosure of the study information 2017/06/01
Last modified on 2018/09/07 14:15:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comparative study between effects of insulin degludec and glargine U300 on nighttime
blood glucose fluctuation
-Investigasion using flash glucose monitoring system-

Acronym

Effects of insulin degludec and glargine U300 on nighttime blood glucose fluctuation

Scientific Title

Comparative study between effects of insulin degludec and glargine U300 on nighttime
blood glucose fluctuation
-Investigasion using flash glucose monitoring system-

Scientific Title:Acronym

Effects of insulin degludec and glargine U300 on nighttime blood glucose fluctuation

Region

Japan


Condition

Condition

diabetes mellitus

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We will compare the effect of insulin degludec and insulin glargine U300 on nocturnal blood glucose fluctuation using FGM (Flash Glucose Monitoring; Freestyle Libre Pro).

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Phase IV


Assessment

Primary outcomes

For the first 5 days and last 5 days in the midnight to 6AM time zone
1 mean blood sugar level
2 Standard Deviation
3 Mean amplitude of glucose excursion

Key secondary outcomes

For the first 5 days and last 5 days in the midnight to 6 AM time zone
1 Percentage of time zone with blood glucose level less than 70 mg per dl and its AUC
2 Percentage of time zone with blood sugar level less than 50 mg per dl and its AUC
3 Percentage of time zone with blood glucose level 140 mg per dl and its AUC


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Cluster

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

1 Install Freestyle Libre Pro (Abbott) for 2 weeks (one sensor).
2 From day 6, switch the basal insulin from insulin degludec to insulin glargine U300, while keeping the same number of units and injection time.

Interventions/Control_2

1 Install Freestyle Libre Pro (Abbott) for 2 weeks (one sensor).
2 From day 6, switch the basal insulin from insulin glargine U300 to insulin degludec, while keeping the same number of units and injection time.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

1 Outpatient visit or hospitalized patients
with diabetes
2 Continue to use insulin deglug or insulin glargine U 300 for three months or more, during which the contents of other diabetes remedies are unchanged
3 HbA1c (NGSP value) is 6% or more but less than 9%

Key exclusion criteria

1 Patients with a clear history of ischemic heart disease (angina, myocardial infarction), ischemic cerebrovascular disease
2 Patients with HbA1c fluctuating by 2% or more within 3 months
3 Severe ketosis, diabetic coma or prematurity
4 Patients with severe infection, preoperative, severe trauma
5 Cases judged by other physicians to be ineligible

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yukihiro Bando

Organization

Fukuiken Saiseikai Hospital

Division name

Internal medicine

Zip code


Address

Funabashi Wadanaka 7-1,Fukui,Fukui.Japan

TEL

0776231111

Email

bando.yukihiro5002@fukui.saiseikai.or.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kazuo Notsumata

Organization

Fukuiken Saisekai Hospital

Division name

Internal medicine

Zip code


Address

Funabashi Wadanaka 7-1,Fukui,Fukui.Japan

TEL

0776231111

Homepage URL


Email

bando.yukihiro5002@fukui.saiseikai.or.jp


Sponsor or person

Institute

Fukuiken Saisekai Hospital

Institute

Department

Personal name



Funding Source

Organization

no source of funding

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 06 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 04 Month 01 Day

Date of IRB


Anticipated trial start date

2018 Year 03 Month 31 Day

Last follow-up date

2018 Year 04 Month 22 Day

Date of closure to data entry

2018 Year 05 Month 01 Day

Date trial data considered complete

2018 Year 05 Month 10 Day

Date analysis concluded

2018 Year 05 Month 15 Day


Other

Other related information



Management information

Registered date

2017 Year 04 Month 02 Day

Last modified on

2018 Year 09 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030797


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name